Skip to main content
user-generated· regulatory

Generic drug approvals accelerate under new FDA leadership

A new FDA Commissioner is expected to prioritize generic drug approvals to lower healthcare costs. The number of generic drug approvals in 2027 will exceed 2025 levels by at least 10%.

regulatory · Prediction Market

Implied probability (Yes)
55%

More regulatory markets

Browse all regulatory markets →

Loading…